Results 271 to 280 of about 98,136 (348)

Multi‐Omics Reveal the Metabolic Changes in Cumulus Cells During Aging

Cell Proliferation, EarlyView.
Fatty acid β‐oxidation was elevated in cumulus cells from older mice. Tryptophan metabolism in aged cumulus cells was active. Supplementing with 5‐HT could mitigate aging damage in oocytes. ABSTRACT Maternal age has been reported to impair oocyte quality.
Liangyue Shi, Hengjie Wang, Shuai Zhu, Minjian Chen, Xuejiang Guo, Qiang Wang, Ling Gu   +6 more
wiley   +1 more source

Clue to the discovery of novel psychotropic drugs based on the control of excessive neuronal function activating by intracellular Ca2+ modulation.

, 1994
Yasuo Watanabe, Takeshi Shibuya
openalex   +1 more source

Trends in novel opioid use and detections in exposures and police drug seizures in New South Wales

Drug and Alcohol Review, EarlyView.
Abstract Introduction Novel opioids, including non‐medical and non‐opium‐based opioids such as fentanyl analogues and nitazenes, pose a significant risk of harm due to their high potency. There is little published data on novel opioid detections and harms in Australia, yet they are implicated in multiple deaths.
Janette L. Smith, Jared Brown, David Atefi, Thanjira Jiranantakan, Vanessa Shaw, Christopher Ewers, Lorraine du Toit‐Prinsloo, Darren M. Roberts   +7 more
wiley   +1 more source

Olof Bäckman & Håkan Leifman: Alcohol and psychotropic drugs - A time series analysis

, 1993

openalex   +1 more source

The prevalence and correlates of self‐reported cannabis use for medicinal, dual and recreational motives in Australia: Findings from the National Drug Strategy Household Survey 2022/2023

Drug and Alcohol Review, EarlyView.
Abstract Introduction Cannabis has been prescribed as a medicine in Australia since 2016. The current study aimed to conduct a descriptive, epidemiological investigation on the prevalence and correlates of cannabis use for different motives (recreational‐only, medical‐only or dual‐use) in Australia.
Danielle Dawson, Gary Chan, Daniel Stjepanović, Valentina Lorenzetti, Wayne D. Hall, Janni Leung   +5 more
wiley   +1 more source

Part II: Cardiac drug and psychotropic drug interactions: significance and recommendations

, 1999
James J. Strain, Gina Caliendo, Jeffrey D. Alexis, R.Sandlin Lowe, Anwarul Karim, Mark Loigman   +5 more
openalex   +1 more source

Contents and Time‐Course of Falsified Alprazolam Detections in New South Wales, Australia

Drug and Alcohol Review, EarlyView.
ABSTRACT Introduction Falsified alprazolam tablets (sometimes called ‘counterfeit alprazolam’) typically do not contain alprazolam and instead contain novel benzodiazepines or other drugs. We describe temporal changes in the number and contents of falsified alprazolam tablets in New South Wales, Australia.
Janette L. Smith, Thanjira Jiranantakan, Una Cullinan, Christopher Ewers, Darren M. Roberts, Jared A. Brown   +5 more
wiley   +1 more source

The impact of the 1987 federal regulations on the use of psychotropic drugs in Minnesota nursing homes.

, 1995
Judith Garrard, Vienna Chen, Bryan Dowd
openalex   +1 more source

A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses?

Drug and Alcohol Review, EarlyView.
ABSTRACT Issues Rising synthetic opioid deaths in North America, and the emergence of nitazene harms has driven concern about novel synthetic opioids (NSO) in Australia. This scoping review aimed to map what is known about NSOs in Australia. Approach Scoping review of peer‐reviewed and grey literature on NSO detections and harms.
Emmanuel Mammoliti, Suzanne Nielsen, Amanda Roxburgh   +2 more
wiley   +1 more source